BSE - Delayed Quote INR

Sunil Healthcare Limited (SUNLOC.BO)

82.93
+2.93
+(3.66%)
At close: June 13 at 3:24:43 PM GMT+5:30
Loading Chart for SUNLOC.BO
  • Previous Close 80.00
  • Open 80.00
  • Bid 82.00 x --
  • Ask 82.80 x --
  • Day's Range 80.00 - 83.00
  • 52 Week Range 60.55 - 87.90
  • Volume 53
  • Avg. Volume 1,160
  • Market Cap (intraday) 850.431M
  • Beta (5Y Monthly) -0.28
  • PE Ratio (TTM) --
  • EPS (TTM) -1.38
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.

www.sunilhealthcare.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUNLOC.BO

View More

Performance Overview: SUNLOC.BO

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUNLOC.BO
6.17%
S&P BSE SENSEX (^BSESN)
3.81%

1-Year Return

SUNLOC.BO
3.66%
S&P BSE SENSEX (^BSESN)
5.61%

3-Year Return

SUNLOC.BO
3.66%
S&P BSE SENSEX (^BSESN)
53.50%

5-Year Return

SUNLOC.BO
3.66%
S&P BSE SENSEX (^BSESN)
140.13%

Compare To: SUNLOC.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUNLOC.BO

View More

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    850.43M

  • Enterprise Value

    1.50B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.02

  • Price/Book (mrq)

    1.27

  • Enterprise Value/Revenue

    1.80

  • Enterprise Value/EBITDA

    12.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.70%

  • Return on Assets (ttm)

    1.52%

  • Return on Equity (ttm)

    -2.09%

  • Revenue (ttm)

    834.21M

  • Net Income Avi to Common (ttm)

    -14.17M

  • Diluted EPS (ttm)

    -1.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    30.85M

  • Total Debt/Equity (mrq)

    102.35%

  • Levered Free Cash Flow (ttm)

    -44.14M

Research Analysis: SUNLOC.BO

View More

Company Insights: SUNLOC.BO

Research Reports: SUNLOC.BO

View More

People Also Watch